... 基因泰克公司(GENENTECH INC) 加州大学(UNIV CALIFORNIA) 人类基因组科学公司(HUMAN GENOME SCI INC) ...
基于34个网页-相关网页
相对于其它抗癌治疗,价格也反映了基因泰克公司对药品的感知价值。
The price also reflected Genentech's perceived value of the drug compared with other cancer treatments.
因此基因泰克公司开发了一种单克隆抗体,这种蛋白将绑定VEGF而使之失效。
So Genentech developed a monoclonal antibody, a type of protein, that would bind to VEGF and disable it.
六月份,雅培公司和基因泰克公司宣布,两公司将运用这种方法合作开发一种抗癌药。
In June, Abbott Laboratories Inc. and Genentech said they would collaborate to develop a cancer drug using this approach.
应用推荐